Intrepid Labs Launches to Transform Drug Formulation with AI and Autonomous Labs

Intrepid Labs Launches to Transform Drug Formulation with AI and Autonomous Labs

TORONTO--(BUSINESS WIRE)--May 12, 2025-

Intrepid Labs Debuts to Revolutionize Drug Formulation with AI - AI-Tech Park

Intrepid Labs’ Valiant platform uses AI and robotics to cut drug formulation timelines from months to days Over $11M USD total raised to-date; latest round led by AVANT BIO Intrepid Labs, a biotechnology company transforming drug formulation development through the use of artificial intelligence (AI) and robotics, emerged from stealth today to accelerate therapeutics development through effective formulations that improve clinical performance. T…

Intrepid Labs Launches With $11M Raised in Total

Intrepid Labs, a Toronto, Canada-based biotechnology company improving drug formulation development through the use of artificial intelligence (AI) and robotics, raised $7M USD in Seed funding. The round was led by AVANT BIO. The raise followed a $4M USD unannounced pre-seed round led by Radical Ventures, with participation from Propagator Ventures. The company intends to […] The post Intrepid Labs Launches With $11M Raised in Total appeared fir…

Biotech Intrepid Labs exits stealth with funding from Radical Ventures and Avant Bio

Toronto-based biotech Intrepid Labs has emerged from stealth with $11 million USD ($15.4 million CAD) in funding to fast-track drug development with machine learning and robotics.  Intrepid is coming off a $7 million USD ($9.8 million CAD) seed round led by life science investor Avant Bio, building on a previously unannounced $4 million USD ($5.6 million) pre-seed round led by Radical Ventures with participation from Propagator Ventures. The bio…

Toronto’s Intrepid Labs Emerges With $11M And AI-Driven Platform To Rebuild Drug Formulation R&D

Toronto-based Intrepid Labs has emerged from stealth with $11 million in total funding to commercialize its autonomous drug formulation platform, Valiant. Designed to overhaul conventional formulation workflows, Valiant combines machine learning, real-time experiment planning, and robotic execution to optimize delivery strategies for small molecules and biologics. Founded in 2023 as a spinout from the University of Toronto, Intrepid Labs is led …

Intrepid Labs raises $7 million to boost AI-driven formulation platform

Toronto-based Intrepid Labs, which we profiled a year ago, has closed an Avant Bio-backed $7 million seed round, bringing its total financing to over $11 million. The company’s Valiant platform is an autonomous lab technology that pairs machine-learning algorithms with robotics to potentially explore up to 1 billion possible formulations. It aims to cut drug-product design… The post Intrepid Labs raises $7 million to expand AI-driven formulation…